Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection.
about
Opposite Interplay between PPAR Gamma and Canonical Wnt/Beta-Catenin Pathway in Amyotrophic Lateral SclerosisIschemic conditioning-induced endogenous brain protection: Applications pre-, per- or post-strokeUpregulation of glutamate transporter GLT-1 by mTOR-Akt-NF-кB cascade in astrocytic oxygen-glucose deprivationElectroacupuncture preconditioning-induced neuroprotection may be mediated by glutamate transporter type 2.Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation.The Concise Guide to PHARMACOLOGY 2013/14: transporters.Effects of long-term pioglitazone treatment on peripheral and central markers of aging.Activation of NR2A receptors induces ischemic tolerance through CREB signaling.Low-dose alcohol consumption protects against transient focal cerebral ischemia in mice: possible role of PPARγ.Expression of astrocytic genes coding for proteins implicated in neural excitation and brain edema is altered after acute liver failure.Involvement of Glutamate transporter-1 in neuroprotection against global brain ischemia-reperfusion injury induced by postconditioning in rats.Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics.The Case for the Use of PPARγ Agonists as an Adjunctive Therapy for Cerebral Malaria.12/15-Lipoxygenase metabolites of arachidonic acid activate PPARγ: a possible neuroprotective effect in ischemic brainPre-conditioning induces the precocious differentiation of neonatal astrocytes to enhance their neuroprotective properties.PPAR gamma activation is neuroprotective in a Drosophila model of ALS based on TDP-43.Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity.The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.Rosiglitazone Promotes White Matter Integrity and Long-Term Functional Recovery After Focal Cerebral Ischemia.The peroxisome proliferator activated receptor gamma agonist pioglitazone increases functional expression of the glutamate transporter excitatory amino acid transporter 2 (EAAT2) in human glioblastoma cells.Glutamate transporters in brain ischemia: to modulate or not?N-Acetylcysteine and Ceftriaxone as Preconditioning Strategies in Focal Brain Ischemia: Influence on Glutamate Transporters Expression.Estrogen attenuates manganese-induced glutamate transporter impairment in rat primary astrocytesPotential Therapeutic Targets for PPARgamma after Spinal Cord Injury.Regulation of Glial Cell Functions by PPAR-gamma Natural and Synthetic Agonists.Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.Reduced early hypoxic/ischemic brain damage is associated with increased GLT-1 levels in mice expressing mutant (P301L) human tau.Neuronal PPARgamma deficiency increases susceptibility to brain damage after cerebral ischemia.PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury.PPAR agonists as therapeutics for CNS trauma and neurological diseasesPioglitazone, a PPARγ agonist rescues depression associated with obesity using chronic unpredictable mild stress model in experimental mice.The potential role of glutamate in the current diabetes epidemic.Ischemic tolerance in the brain: endogenous adaptive machinery against ischemic stress.Oligodendrocyte pathophysiology and treatment strategies in cerebral ischemia.Pleiotropic role of PPARγ in intracerebral hemorrhage: an intricate system involving Nrf2, RXR, and NF-κB.Neurotransmitters and Neuropeptides: New Players in the Control of Islet of Langerhans' Cell Mass and Function.Metabolic and Inflammatory Adaptation of Reactive Astrocytes: Role of PPARs.Excitatory amino acid transporter 2 and excitatory amino acid transporter 1 negatively regulate calcium-dependent proliferation of hippocampal neural progenitor cells and are persistently upregulated after injuryPeroxisome proliferator-activated receptor-gamma: potential molecular therapeutic target for HIV-1-associated brain inflammation.Distinct modulation of voltage-gated and ligand-gated Ca2+ currents by PPAR-gamma agonists in cultured hippocampal neurons.
P2860
Q26742196-441572A8-5476-4E6E-8732-340557704607Q28082979-26B0E30D-A4E0-4A9B-9E6C-6941156D8CBDQ28576235-5CB51AA8-6BE4-49F8-9D45-DACF3F27FD67Q30410519-29E948FE-915D-467E-A6ED-B2D4EE1ED65DQ30470076-226EAEC1-FFC4-4E8A-BBBA-DE40EE280AAFQ30486743-060B6282-33BC-4C60-BBE9-C0278C4BAB63Q33818388-E5A6AB47-ED38-47D8-960E-2E74F156C825Q34171285-2BC5DB3A-9793-478D-8F85-F58D98E4A8B2Q34358879-EFF605D1-A361-4DE9-AC0B-2D8599663B2CQ34380538-D8DADF46-1694-43A8-A778-13CC900CFCEAQ34396051-80302EF9-9DCF-47E3-9EE1-57C970A57B6DQ35087565-D9CC89D6-0552-4BEC-B205-796DE5CCCD67Q35101529-098F05FB-BCB3-4C33-BCC8-EEE5F3CE7F77Q35120876-9B2A8059-ABD5-48BC-941A-0047BD2512A9Q35157711-28475258-6B21-40AC-A939-DC354EDCF3DCQ35239387-FBFA924D-2FD7-43E5-A41C-1B729FEB176BQ35577677-17AA4B07-CA9A-4639-AB67-094CC368F3EDQ36137988-A66C49BF-52FA-4505-A05A-C4CE73B818F8Q36191138-1D757C8A-09C4-4EC8-80B5-3AACB9A4FA1CQ36356318-6DEE7847-0BDD-46E8-AD6E-A899FD3A3D2AQ36745208-1FDD2C60-E3C9-49D4-9C39-8094233FCBEFQ36764301-A28C3126-51D3-4343-95A9-A5CDB367CC96Q36926205-E6D671DD-2DF3-47CD-8E96-429A560DAD7DQ37134018-201667C5-D203-4E9E-99B4-17465EC85F1AQ37157531-4DEA1332-2DA9-4CD7-A574-93FD47C6726DQ37158226-AABEC4BB-04EC-4F6C-BCE2-B065A40DD640Q37181349-CE32C345-773E-43C9-9896-5F2599F54D48Q37335663-1EBFF3C2-1783-4FD3-B9FD-1984F3DAB090Q37362740-D207C4EE-866D-40E0-87ED-8E651D9ECB90Q37400355-00D8BEA2-7710-4E13-A1A7-68B730DED109Q37486869-184290CC-0A6C-4392-83B1-F44A99BDA41EQ37973276-EDF12C15-E4F9-4FD2-BE18-C7B0A5359065Q37981130-33640CD1-652C-4B9E-9AA5-CEA1FF330B00Q38202292-CE61B815-40ED-41C0-AF85-85C1D560FC3BQ38272127-EC0B2FAB-0949-443A-A072-260221FEC5F4Q38579025-DE47B58D-8CA5-490E-988E-3D9E71FF52BFQ38777732-7357A5D7-CEAA-42CC-9CEF-968731CA7A95Q39400315-E46039F6-CDD9-40C4-84C2-60F85A4BDA31Q40050469-EF625457-4CEC-4C84-A9EE-FA74B60A0031Q41148387-3BCEAD3A-B112-40E5-933F-E534D42CE449
P2860
Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Ischemic preconditioning revea ...... e involved in neuroprotection.
@en
Ischemic preconditioning revea ...... e involved in neuroprotection.
@nl
type
label
Ischemic preconditioning revea ...... e involved in neuroprotection.
@en
Ischemic preconditioning revea ...... e involved in neuroprotection.
@nl
prefLabel
Ischemic preconditioning revea ...... e involved in neuroprotection.
@en
Ischemic preconditioning revea ...... e involved in neuroprotection.
@nl
P2093
P2860
P50
P356
P1476
Ischemic preconditioning revea ...... ne involved in neuroprotection
@en
P2093
Alejandro Romera
Cristina Romera
Florentino Nombela
Jesús R Morales
Joaquín Serena
José Vivancos
Judith Mallolas
Pedro Lorenzo
P2860
P304
P356
10.1038/SJ.JCBFM.9600438
P577
2007-01-10T00:00:00Z